Seeing Is Believing
Currently out of the existing stock ratings of Oren Livnat, 14 are a HOLD (7.53%), 172 are a BUY (92.47%).
Analyst Oren Livnat works with a stock forecast success ratio of 31.8% fulfilled within 183.96 days on average. Previously, Oren Livnat worked at HCWAINWRIGHT.
Oren Livnat’s has documented 347 price targets and ratings displayed on 23 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on XERS, Xeris Pharmaceuticals at 07-Mar-2024.
Analyst best performing recommendations are on MNLO (MENLO THERAPEUTICS).
The best stock recommendation documented was for MNLO (MENLO THERAPEUTICS) at 5/12/2020. The price target of $2.5 was fulfilled within 16 days with a profit of $0.69 (38.12%) receiving and performance score of 23.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
45
$15.96 (54.96%)
83
22 days ago
1/3 (33.33%)
$14.36 (46.87%)
239
Buy
57
$27.96 (96.28%)
57
25 days ago
13/23 (56.52%)
$27.8 (95.21%)
233
Buy
45
$15.96 (54.96%)
45
28 days ago
2/12 (16.67%)
$16.14 (55.93%)
878
Buy
45
$15.96 (54.96%)
58
28 days ago
0/5 (0%)
$16.14 (55.93%)
Buy
57
$27.96 (96.28%)
60
1 months 21 days ago
0/2 (0%)
$29.3 (105.78%)
Which stock is Oren Livnat is most bullish on?
Which stock is Oren Livnat is most reserved on?
What Year was the first public recommendation made by Oren Livnat?